Log in

NASDAQ:INFIInfinity Pharmaceuticals Insider Trades

+0.01 (+1.14 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $0.89
50-Day Range
MA: $0.93
52-Week Range
Now: $0.89
Volume32,300 shs
Average Volume186,438 shs
Market Capitalization$51.16 million
P/E RatioN/A
Dividend YieldN/A

Insider Trades

Infinity Pharmaceuticals (NASDAQ:INFI) Insider Buying and Selling Activity

Insider Ownership Percentage: 12.12%

Insider Buying and Selling by Quarter

Infinity Pharmaceuticals (NASDAQ INFI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2018Value Fund L P BiotechnologyMajor ShareholderBuy175,000$1.20$210,000.00  
11/28/2018Value Fund L P BiotechnologyMajor ShareholderBuy100,000$1.30$130,000.00  
11/21/2018Value Fund L P BiotechnologyMajor ShareholderBuy1,469,826$1.37$2,013,661.62  
11/19/2018Bvf Partners L P/IlMajor ShareholderBuy1,465,126$1.37$2,007,222.62  
11/15/2018Bvf Partners L P/IlMajor ShareholderBuy91,474$1.35$123,489.90  
11/13/2018Bvf Partners L P/IlMajor ShareholderBuy604,208$1.35$815,680.80  
10/1/2018Adelene Q. PerkinsCEOSell5,000$2.82$14,100.00  
8/15/2018Jeffery KutokInsiderSell8,180$2.01$16,441.806,133  
6/22/2018Jeffery KutokInsiderSell14,313$2.00$28,626.0014,313  
6/21/2018Bvf Partners L P/IlMajor ShareholderBuy425,531$1.65$702,126.15  
6/19/2018Bvf Partners L P/IlMajor ShareholderBuy3,516,560$1.65$5,802,324.00  
4/10/2018Value Fund L P BiotechnologyMajor ShareholderBuy1,510,000$1.97$2,974,700.00  
3/5/2018Adelene Q PerkinsCEOSell5,000$2.78$13,900.00607,252  
12/6/2017Lawrence E BlochPresidentBuy500,000$1.81$905,000.00580,944  
10/4/2017Value Fund L P BiotechnologyInsiderBuy1,600,046$1.26$2,016,057.96  
3/17/2017Michael C VenutiDirectorSell6,250$3.48$21,750.0050,000  
1/3/2017Value Fund L P BiotechnologyMajor ShareholderBuy4,379$1.34$5,867.86  
12/30/2016Value Fund L P BiotechnologyMajor ShareholderBuy742,401$1.34$994,817.34  
12/20/2016Value Fund L P BiotechnologyMajor ShareholderBuy654,921$1.31$857,946.51  
12/13/2016Sujay KangoInsiderSell75,000$1.28$96,000.0050,590  
12/12/2016Sujay KangoInsiderSell25,009$1.30$32,511.7050,590  
12/2/2016Value Fund L P BiotechnologyMajor ShareholderBuy201,394$1.19$239,658.86  
6/25/2015Adelene Q PerkinsCEOSell5,000$10.93$54,650.00  
6/15/2015Vito J PalombellaInsiderSell4,737$10.97$51,964.89  
5/27/2015Adelene Q PerkinsCEOSell10,000$12.81$128,100.00  
5/14/2015Adelene Q PerkinsCEOSell10,000$12.18$121,800.00  
3/16/2015Adelene Q PerkinsCEOSell20,000$16.00$320,000.00  
1/29/2015Adelene Q PerkinsCEOSell20,000$14.83$296,600.00  
12/15/2014Vito J PalombellaInsiderSell4,737$16.32$77,307.84  
11/26/2014Vito J PalombellaInsiderSell4,736$15.00$71,040.00  
9/30/2014Anthony B EvninDirectorSell112,451$13.56$1,524,835.56  
9/3/2014Vito J PalombellaInsiderSell9,472$15.39$145,774.08  
11/27/2013Anthony B EvninDirectorSell163,864$14.82$2,428,464.48  
9/13/2013Adelene PerkinsCEOSell45,000$20.72$932,400.00447,535  
6/20/2013Vito J PalombellaInsiderSell23,150$18.53$428,969.50  
11/26/2012Christopher M LindblomInsiderSell13,885$25.73$357,261.05  
9/7/2012Co BeaconMajor ShareholderBuy5,416,565$14.50$78,540,192.50  
(Data available from 1/1/2013 forward)
This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.